|drug524||N-acetylcysteine+ Fuzheng Huayu Tablet Wiki||1.00|
|D011658||Pulmonary Fibrosis NIH||0.58|
There is one clinical trial.
Inflammation is the early stage of fibrosis. Serious patients are more likely to develop into pulmonary fibrosis, which affects the recurrence of lung function or even threatens life and health. This study is planned to observe the efficacy and safety of Fuzheng Huayu tablets in the treatment of pulmonary fibrosis after COVID-19.
Description: Evaluation of Pulmonary fibrosis Improvement. HRCT images are graded from 1 to 6, higher scores mean a worse outcome.Measure: High-resolution computed tomography (HRCT) score Time: Week 24
Description: Evaluation of Lung Function ImprovementMeasure: Lung function including FVC, FVC as a percentage of projected value and DLco Time: Week 24
Description: Times of acute exacerbations during treatmentMeasure: Times of acute exacerbation Time: Week 24
Description: Measured by a 6-minute walking testMeasure: Six-minute walk distance Time: Week 24
Description: Using the scale revised by British modified Medical Research Council (MMRC) which divided patients into five degrees.Higher scores mean a worse outcome.Measure: Dyspnea Scores Time: Week 24
Description: Evaluation of Pulmonary fibrosis Improvement on CT which is calculated by formula.Measure: Composite physiological index Time: Week 24